@article{f175c710cc10491a83680ad00ddb8682,
title = "Prediction of pre-eclampsia: review of reviews",
abstract = "先兆子痫的预测:评论回顾 目的: 初步研究和系统评论根据预测先兆子痫的不同因素提供各种准确的估计值。本研究的目的是回顾已发表的系统评论,核对现有检测能力的证据以便预测先兆子痫,确定未来研究的高价值途径,并尽量减少该领域未来研究的浪费。 方法: 检索联机医学文献分析和检索系统(MEDLINE)、荷兰医学文摘数据库(EMBASE)和Cochrane图书馆包括DARE(效果评论摘要数据库),从建立数据库到2017年3月,并检索了相关文章的参考文献,不受语言限制,对先兆子痫的预测进行系统回顾和meta分析。使用多系统评价膀胱问卷(AMSTAR)工具和QUIPS处理系统工具的修改版本评估纳入评论的质量。我们评估了搜索的全面性、样本大小、测试和评价结果、数据综合方法、预测能力估计、与研究人群相关的偏差风险、预测因素和结果的测量值、研究淘汰率和混杂设计的调整。 结果: 共确定2444篇引文,其中包括126篇评论,报道了90多个预测因素和52种先兆子痫的预测模型。约三分之一(n=37(29.4%)的评论只研究了预测先兆子痫的生化标记,31篇(24.6%)研究了与先兆子痫的遗传关联,46篇(36.5%)报告了临床特征,4篇(3.2%)仅评价了超声标志物,6篇(4.8%)研究了联合检测;另外两篇(1.6%)评论评估了对先兆子痫筛查试验的初步研究。评论包括两项和265项初步研究,其中最大型评论纳入了多达25,356,688名女性。只有大约一半(n=67(53.2%))的评论评估了纳入研究的质量。许多纳入的评论有很高的偏差风险,特别是在人群代表性和研究淘汰率方面。80%(n=106(84.1%)以上的评论采用Meta分析方法总结研究结果。32项研究(25.4%)缺乏关于资金的正式说明。最佳检测指标为体重指数(MBI)>35 kg.m-2 ,特异性92%(95% CI,89-95%),敏感性21%(95% CI,12-31%);BMI>25 kg.m-2 ,特异性73%(95% CI,64-83%),敏感性47%(95% CI,33-61%);妊娠早期子宫动脉搏动指数或阻力指数>90%(特异性93%(95% CI,90%-96%)和敏感性26%(95% CI, 23%-31%));胎盘生长因子(特异性89%(95% CI,89%-89%),敏感性65%(95% CI,63%-67%);胎盘蛋白13(特异度88%(95% CI,87%-89%),敏感性37%(95% CI, 33%-41%))。 没有一种单一标记物具有适合常规临床使用的测试性能。模型结合标记物显示有希望,但没有一种模型经过外部验证。 结论: 鉴于大量已发表的评论受制于初级预测研究的共同局限性,本评论回顾引发了对这一领域进行进一步汇总meta分析的必要性的质疑。为了开发和验证新的预测模型,促进对先兆子痫的预测,并最大限度地减少该领域的进一步研究浪费,需要对预测标志物进行前瞻性、精心设计的研究,最好是随机干预研究,并与个体患者数据的meta分析相结合。.",
keywords = "hypertension in pregnancy, pre-eclampsia, prediction, screening, systematic review",
author = "R. Townsend and A. Khalil and Y. Premakumar and J. Allotey and Snell, {K. I.E.} and C. Chan and L. Chappell and R. Hooper and M. Green and Mol, {B. W.} and B. Thilaganathan and S. Thangaratinam and J. Allotey and K. Snell and C. Chan and R. Hopper and J. Dodds and E. Rogozinska and K. Khan and L. Poston and L. Kenny and J. Myers and B. Thilaganathan and L. Chappell and Mol, {B. W.} and {Von Dadelszen}, P. and A. Ahmed and M. Green and A. Khalil and K. Moons and Riley, {R. D.} and S. Thangaratinam",
note = "Funding Information: B.W.M. is supported by a NHMRC Practitioner Fellowship (GNT1082548). Funding Information: Twenty-one (16.7%) studies declared that no funding had been received, while 32 (25.4%) lacked a formal statement regarding funding. Of the remaining 73 studies, 14 (19.2%) declared multiple funding sources. The majority of these studies (51/73 (69.9%)) that declared their funding source had been sponsored by national or regional governmental bodies (e.g. National Institute for Health Research (NIHR), National Institutes of Health, Canadian Institutes of Health Research, Health Technology Assessment (HTA), National Health and Medical Research Council (NHMRC)). Nearly one quarter (21.9%) of the studies were funded through academic institutions, 19.2% by charitable bodies, 4.1% received funding from industry and 9.5% were funded by international bodies, chiefly by the World Health Organization (WHO). Funding Information: B.W.M. is supported by a NHMRC Practitioner Fellowship (GNT1082548). B.W.M. reports consultancy for ObsEva, Merck and Guerbet. S.T. is the chief investigator of the NIHR-funded IPPIC IPD-MA to predict pre-eclampsia. Publisher Copyright: Copyright {\textcopyright} 2018 ISUOG. Published by John Wiley & Sons Ltd.",
year = "2019",
month = jul,
day = "1",
doi = "10.1002/uog.20117",
language = "English",
volume = "54",
pages = "16--27",
journal = "Ultrasound in Obstetrics and Gynecology",
issn = "0960-7692",
publisher = "John Wiley & Sons Inc.",
number = "1",
}